Gowling WLG’s advised Sosei Heptares on the deal. Sosei Heptares on its collaboration with San Diego based Neurocrine Biosciences Inc to develop novel muscarinic receptor agonist...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here